Efficacy of selected dietary supplements and pharmacological agents on metabolic and oxidative stress outcomes in metabolic dysfunction-associated fatty liver disease (MAFLD): a Bayesian network meta-analysis.

Front Pharmacol · 2025 · PMC12894030 · PMID 41695987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

did not reach statistical significanceno p-value reported

Although the results of metformin (MD: −0.18; 95% CrI: −0.39 to 0.032) and bioactive metabolic regulators (MD: −0.15; 95% CrI: −0.37 to 0.077) did not reach statistical significance, both showed a decreasing trend in HbA1c, ranking second (SUCRA = 0.75) and third (SUCRA = 0.70), respectively.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.